Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.
about
Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibilityThe use of laboratory tests in the diagnosis of SLEDecreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosusIntrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementCardiovascular comorbidity in rheumatic diseases: a focus on heart failurePredictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosusClinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disordersSystemic lupus erythematosus on the Caribbean island of Curaçao: an epidemiological investigation.Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?Is pregnancy a risk factor for rheumatic autoimmune diseases?Long-term cardiac changes in patients with systemic lupus erythematosusSicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables.Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatologyRenal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China.Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study.Corticosteroids: do they damage the cardiovascular system?Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosusSemiquantified noncalcified coronary plaque in systemic lupus erythematosus.Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus.Systemic lupus erythematosus with nephropathySystemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.Impaired arterial stiffness in systemic lupus ertythematosus - correlations with inflammation markersPhenome-wide association studies uncover a novel association of increased atrial fibrillation in males with systemic lupus erythematosus.Androgen-Induced Immunosuppression.Atherosclerotic disease is the predominant aetiology of acute coronary syndrome in young adults.
P2860
Q21195675-3650D8F7-F76C-46C3-8765-CAD22FB98FA5Q24682977-197A87D5-A916-4F12-AFE6-34301C34402AQ24793525-FD5D3E6F-5168-4144-973D-FF123FF6A6BDQ24798439-81ECE4B8-5639-4042-A26B-0C6284835517Q26823443-2366A7B4-3307-44E5-B3B0-C3596E1D8586Q33387473-EE63AA1B-35BA-41C3-83EE-F576C717CF92Q33389669-C2AA18BF-8BEB-4229-A49E-EFBF5063B74AQ33491307-AC1E10F2-95FC-4671-9A77-6F79B7DCC2E3Q33566701-F2A2E6EA-80F4-4E8C-B15F-C2B0FB3F6CE3Q33584094-8E1CDF88-64C9-4044-A26B-FCACAEA9035DQ33748970-F176CB2A-6EF7-45A9-99EE-91BD547BBEE0Q33881567-BF0D7B6D-091F-4D85-9B97-04CB3F96F836Q34118068-D370AE03-762F-4857-A0AA-BA41F6093622Q34699205-768DA1AA-9C4E-43D5-B67D-730D158145AFQ35549969-1F2A236C-57DC-4A59-A7AB-5C27A4E2A811Q35551137-F003DDA5-661B-4171-8E97-C718A22EAABDQ35551526-27C422C6-8620-4586-B289-8EA55E22DC1DQ35552164-BF6CB322-E6D7-429A-AB11-F708D703F6E2Q35553057-805C6DDD-D622-4705-AD80-9F8AB3C9784BQ36059492-513D37E6-473D-4416-9D26-03437F91E22AQ36257238-D683F027-991A-4450-BC7D-0126E7EE41C7Q36307414-5E6A17F2-14A5-456C-9F04-118A3FD735C5Q36679823-F3139D96-069C-4EF7-A7DE-94D6D9D1CF88Q36683387-C0DC2EA1-7514-4DFD-8256-D8C333C8C081Q36709328-8F6EA0F4-017A-4603-95B3-A87B78A3F137Q36906572-1595EA3A-B1FA-4263-AFAD-45BC305F5D36Q36987544-12D3CAC3-09D5-446C-8A91-696F925638DBQ37033345-E7F33A47-6003-4184-B0DF-80D1E0207BBEQ37161550-02FCD02A-1B03-4E88-BD6C-1F99F718759EQ37715144-0C524A75-FC5C-4A00-91D1-156A7220D068Q52685013-C232A7B4-3AE5-4EA2-9CC1-34FB011B937DQ55357541-79EF214E-C1AD-4B36-AE48-A21E8C6B0B41Q55396189-91978021-F051-42A2-B05B-366BFC29BE44
P2860
Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Outcome in systemic lupus eryt ...... nts from a defined population.
@en
Outcome in systemic lupus eryt ...... nts from a defined population.
@nl
type
label
Outcome in systemic lupus eryt ...... nts from a defined population.
@en
Outcome in systemic lupus eryt ...... nts from a defined population.
@nl
prefLabel
Outcome in systemic lupus eryt ...... nts from a defined population.
@en
Outcome in systemic lupus eryt ...... nts from a defined population.
@nl
P2093
P1433
P1476
Outcome in systemic lupus eryt ...... nts from a defined population.
@en
P2093
P304
P356
10.1016/0002-9343(89)90255-6
P407
P577
1989-05-01T00:00:00Z